INTUITIVE SURGICAL INC (ISRG) Form 10-Q — Oct 21, 2026
Intuitive Surgical reported Q3 2026 revenue of $3,048.7 million, up roughly 22% from $2,505.1 million a year earlier, with nine-month revenue of $8,711.8 million versus $7,198.5 million. However, diluted EPS fell to $1.49 from $1.95 as the company recorded a $450 million charge to settle the da Vinci Surgical Robot Antitrust Litigation class action, agreed to following a mediation in October 2026 and still subject to court approval.
Key figures
- Eps
- 1.49
- Net Income
- 522800000
- Revenue Yoy
- 21.7% (Q3 2026 vs Q3 2025)
- Shares Outstanding
- 346643718
- Tariff costs q3
- $23.4 million
- Ieepa refunds q3
- $27.8 million
- Nine month revenue
- $8,711.8 million
- Nine month buybacks
- $4,446.3 million
- Q3 2025 diluted eps
- 1.95
- Nine month net income
- $2,173.6 million
- Installed base da vinci 5
- 2023
- Q3 litigation settlement charge
- $450 million
- Remaining buyback authorization
- $1.8 billion
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.